Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten Schlomm

Showing results (11-20 of 359) with videos related to

Pageof 36
Sort By:
European Urology|November 26, 2008
Editorial comment on: Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature reviewSascha A Ahyai, Thorsten Schlomm
European Urology|December 17, 2013
Improving outcome of surgical procedures is not possible without adequate quality measurementThorsten Schlomm, Hartwig Huland, Markus Graefen
European Urology|August 5, 2015
Associations Do Not Equal Causation: Clinical Relevance of Statistical Associations of Phosphodiesterase Type 5 Inhibitors with Prostate Cancer Progression and MelanomaStacy Loeb, Thorsten Schlomm, Pär Stattin
European Urology|December 31, 2013
Outcome of radical prostatectomy: is it the approach or the surgical expertise?Markus Graefen, Burkhard Beyer, Thorsten Schlomm
Der Urologe. Ausg. A|June 22, 2018
[Reply to: PSA screening : Possible uses and harm by N. Keller, M. Jenny, G. Gigerenzer, R. Ablin]Carsten Stephan, Thorsten Schlomm, Klaus Jung
Der Urologe. Ausg. A|January 21, 2021
[Innovations in urology: essential for progress]Arkadiusz Miernik, Thorsten Schlomm, Christian Bolenz
Methods in Molecular Biology (Clifton, N.J.)|August 7, 2010
From gene to clinic: TMA-based clinical validation of molecular markers in prostate cancerThorsten Schlomm, Felix Kh Chun, Andreas Erbersdobler
Der Urologe. Ausg. A|February 14, 2022
[Molecular diagnostics and molecular tumor board in uro-oncology : Precision medicine using the example of metastatic castration-resistant prostate cancer]Kira Kornienko, Rana Tahbaz, Henning Plage, et al.
European Urology|April 28, 2015
The aging prostate is never "normal": implications from the genomic characterization of multifocal prostate cancersThorsten Schlomm, Joachim Weischenfeldt, Jan Korbel, et al.
World Journal of Urology|March 6, 2007
Molecular staging of prostate cancer in the year 2007Thorsten Schlomm, Andreas Erbersdobler, Martina Mirlacher, et al.
Pageof 36

Showing results (11-20 of 359) with videos related to

Sort By:
Pageof 36
European Urology|November 26, 2008
Editorial comment on: Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature reviewSascha A Ahyai, Thorsten Schlomm
European Urology|December 17, 2013
Improving outcome of surgical procedures is not possible without adequate quality measurementThorsten Schlomm, Hartwig Huland, Markus Graefen
European Urology|August 5, 2015
Associations Do Not Equal Causation: Clinical Relevance of Statistical Associations of Phosphodiesterase Type 5 Inhibitors with Prostate Cancer Progression and MelanomaStacy Loeb, Thorsten Schlomm, Pär Stattin
European Urology|December 31, 2013
Outcome of radical prostatectomy: is it the approach or the surgical expertise?Markus Graefen, Burkhard Beyer, Thorsten Schlomm
Der Urologe. Ausg. A|June 22, 2018
[Reply to: PSA screening : Possible uses and harm by N. Keller, M. Jenny, G. Gigerenzer, R. Ablin]Carsten Stephan, Thorsten Schlomm, Klaus Jung
Der Urologe. Ausg. A|January 21, 2021
[Innovations in urology: essential for progress]Arkadiusz Miernik, Thorsten Schlomm, Christian Bolenz
Methods in Molecular Biology (Clifton, N.J.)|August 7, 2010
From gene to clinic: TMA-based clinical validation of molecular markers in prostate cancerThorsten Schlomm, Felix Kh Chun, Andreas Erbersdobler
Der Urologe. Ausg. A|February 14, 2022
[Molecular diagnostics and molecular tumor board in uro-oncology : Precision medicine using the example of metastatic castration-resistant prostate cancer]Kira Kornienko, Rana Tahbaz, Henning Plage, et al.
European Urology|April 28, 2015
The aging prostate is never "normal": implications from the genomic characterization of multifocal prostate cancersThorsten Schlomm, Joachim Weischenfeldt, Jan Korbel, et al.
World Journal of Urology|March 6, 2007
Molecular staging of prostate cancer in the year 2007Thorsten Schlomm, Andreas Erbersdobler, Martina Mirlacher, et al.
Pageof 36